Quantum-Si
GenomeWeb Top 40 Rises 3 Percent in November Amidst Mixed Broader Market
In comparison, the Dow Jones Industrial Average rose 8 percent and the Nasdaq rose 6 percent, but the Nasdaq Biotech Index was in negative territory, falling by less than 1 percent.
The firm claims the system, called Proteus, will ultimately enable the analysis of billions of peptides, though the initial version, slated for 2026, will cover around 50 million.
Quantum-Si Laying off 23 Percent of Workforce
The company said it is making the cuts to focus its resources on efforts including the development of its recently announced Proteus protein sequencing platform.
Quantum-Si Inks Deals for Development of New Proteomics Platform, Distribution Agreement
The firm is working with Planet Innovation, SkyWater Technology, and Nvidia on a new proteomics platform and signed a distribution deal for existing products with Avantor.
QSI More Than Triples Q3 Revenues but Misses Internal Target, Receives Delisting Notice
The company said it is unlikely to reach its full-year 2024 revenue guidance as several customers pushed back planned purchases of its Platinum protein sequencer.